The Economics of Reproducibility in Preclinical Research - Test2 - elhamkhani - TriplyDB

The Economics of Reproducibility in Preclinical Research

The Economics of Reproducibility in Preclinical Research

http://www.wikidata.org/entity/Q28548038

about

Meta-Research: Broadening the Scope of PLOS Biology Better reporting for better research: a checklist for reproducibility Better reporting for better research: a checklist for reproducibility Better reporting for better research: a checklist for reproducibility Using prediction markets to estimate the reproducibility of scientific research Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research Managing risks in drug discovery: reproducibility of published findings Making the most of peer review Impact of genetic background and experimental reproducibility on identifying chemical compounds with robust longevity effects Show and tell: disclosure and data sharing in experimental pathology Open data in drug discovery and development: lessons from malaria INFRAFRONTIER: a European resource for studying the functional basis of human disease Quality Issues of Research Antibodies.Quality Assurance in Biobanking for Pre-Clinical Research Bridging Translation by Improving Preclinical Study Design in AKI Standardization of high content imaging and informatics Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor Optimized design and analysis of preclinical intervention studies in vivo Developing a Collaborative Agenda for Humanities and Social Scientific Research on Laboratory Animal Science and Welfare Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases Contextual sensitivity in scientific reproducibility THE ART OF SMART SCIENCE: WEAVING THEORY AND RISKY STUDY DESIGN INTO PSYCHOPATHOLOGY RESEARCH AND RDOC The impact of structural genomics: the first quindecennial Safeguarding Structural Data Repositories against Bad Apples From Gutenberg to Open Science: An Unfulfilled Odyssey.Metaresearch for Evaluating Reproducibility in Ecology and Evolution.Reproducibility2020: Progress and priorities."Life in Data"--Outcome of a Multi-Disciplinary, Interactive Biobanking Conference Session on Sample Data.Research Reproducibility in Longitudinal Multi-Center Studies Using Data from Electronic Health Records.A critical analysis of cancer biobank practices in relation to biospecimen quality Assessing the utility of an institutional publications officer: a pilot assessment.Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation Computational Methodologies for Real-Space Structural Refinement of Large Macromolecular Complexes.Hippo pathway mediates resistance to cytotoxic drugs.Introduction to the Rosetta Special Collection.A Simple and Low-Cost Monitoring System to Investigate Environmental Conditions in a Biological Research Laboratory Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.Strong Inference in Mathematical Modeling: A Method for Robust Science in the Twenty-First Century.The Researchers' View of Scientific Rigor-Survey on the Conduct and Reporting of In Vivo Research.Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease

P2860

Q24288788-979BDA6F-DBFC-406F-8828-9E1AF8C3EEB5 Q24288839-2D53DF53-AD98-4851-B75D-B157A1C6D6B4 Q24288858-F44B5705-C09F-46A1-9389-09C30A440C95 Q24288890-60C00094-87DF-420B-A001-E26FA1D72553 Q24289249-2A0E8AC3-8C60-4528-97E6-B369E91DCF8B Q24289253-7C5D061A-6395-44CC-943B-128E7227C72A Q24289508-F8E896B9-3C73-4456-9040-69555977F3B9 Q24669504-324D6426-EF7E-4378-B602-AD678A7F2270 Q26538688-D8C58B49-BA10-4919-8BEF-0B6CCBDF3B96 Q26739933-E93FFC56-8591-4CC8-A139-50F73D332DB6 Q26742211-847791A4-30EB-4771-8F27-075A0D2AA49F Q26748700-83B15AD2-A660-47AE-A014-E6DCAFF2A177 Q26751289-383AAB6A-AF33-4899-AF16-6E6EBF58B244 Q28074602-38A070D4-6112-4AD7-8DD0-68892EA0B817 Q28084530-A567C865-37E4-4D58-BF02-D424A932295B Q28547643-074DA623-D7B2-4B71-BCFA-6D40AA359907 Q28590246-6E737F94-CCC9-4836-836D-95E562C76885 Q28595545-B7B3FECE-7119-4B81-9CE2-6D6FA70F527C Q28596147-DFE487A8-E6EE-4B12-8670-A4B9B1C71D93 Q28597442-8F23532D-CAFF-45BB-81CE-6FD68F580647 Q28597738-AD19F4D3-AD6A-4A2C-A94A-B83550B04EFB Q28602008-4D2E9C05-F509-48AD-B840-326CCDAB6D70 Q30277230-9E87F02C-FCE1-4E05-A204-0D1567655CB4 Q30277616-C9C52375-2956-4315-B25E-3BA476DE2B5D Q30490232-E4A9104F-1F7E-455C-AA96-C831959953EE Q30491949-13FE8A02-AEF5-44A0-B8A1-DFB0E480AC60 Q30492016-02414EB6-DCF8-4A31-9392-87190A40EC85 Q31039724-46A8A329-FEB9-48AB-AD7C-CFB3B992F8B3 Q31124888-1FBBA859-93F3-42A8-B6AB-299AB9146F68 Q33639763-92ABD161-7A7D-498A-B7A5-A7B079C4EB0F Q33756337-4BE89D35-B4F7-4374-9D7D-42FC9ADC3B49 Q33782901-5CC68D69-9A02-4B9D-9735-DC037B92D2E0 Q33926329-E40560A6-F74D-4534-B0CA-25B1B2FD6857 Q34555337-1DFD30B3-3BD9-47B6-8AE9-66C703D72329 Q35880639-BB0AFE53-DE58-49B0-9C36-E19791CB85CD Q35895237-90448D25-BCCE-4702-9B5D-6FEAE5964902 Q35933820-7A98EAF3-674C-4B69-ACEC-B27593049720 Q36097151-E0EA3426-2480-4F3F-9E47-1F67ED8712F9 Q36211830-18E34894-5B1B-4D35-8183-008EC223A140 Q36275707-3CF07079-A008-4823-A525-E54EEC99CE39

P2860

The Economics of Reproducibility in Preclinical Research

http://www.wikidata.org/entity/Q28548038

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The Economics of Reproducibility in Preclinical Research

@ast

The Economics of Reproducibility in Preclinical Research

@en

The Economics of Reproducibility in Preclinical Research

@nl

type

label

The Economics of Reproducibility in Preclinical Research

@ast

The Economics of Reproducibility in Preclinical Research

@en

The Economics of Reproducibility in Preclinical Research

@nl

prefLabel

The Economics of Reproducibility in Preclinical Research

@ast

The Economics of Reproducibility in Preclinical Research

@en

The Economics of Reproducibility in Preclinical Research

@nl

P1433

Q28548038-7FA873B9-FF03-46A2-9B5D-F4B8D2DB650A

P1476

Q28548038-61F2A25C-B85F-4240-AB64-8D50778E520F

P2093

Q28548038-214F6B15-C9F1-4D02-9584-C10053214FFE

Q28548038-D224DD4D-7425-426E-AE52-D8905365A85F

Q28548038-DF78CF15-9293-4035-ABF7-765F35B5C0CB

P2860

Q28548038-06384923-DF92-456D-B146-5F830158B8B1

Q28548038-0A72EB80-BFD0-4AEE-92F2-DFF07192ECCD

Q28548038-277367F9-B6EA-4F85-8C00-AFFAFC77B8A7

Q28548038-38F5C28A-C8EA-47E5-958D-A4DDCA9367A8

Q28548038-38FDC201-3F4B-4C45-A5AC-ED7CC58952E8

Q28548038-3E672D54-A036-4A83-9989-3F24D362ED2B

Q28548038-3F9A688C-B859-4476-AB82-C7FE86E54902

Q28548038-474B155E-2C3D-472D-B8EF-C1E58D47CE51

Q28548038-55797B64-188B-454B-992A-9A2C4C4BCF96

Q28548038-594253C7-BB92-4244-B62B-4D0A70FFF7CE

P304

Q28548038-C761E0E3-746F-4921-B907-29B2AC74FC7C

P31

Q28548038-72FB8C1F-8215-4F85-AD96-915C87B999FE

P3181

Q28548038-CF77E38A-D48C-4546-8C50-A19C9A4887DE

P356

Q28548038-CD87AAE4-7869-49DB-9958-04D01E40F07B

P407

Q28548038-C8571521-2B16-4A1B-9707-77905F137B72

P433

Q28548038-9CFC4C54-332D-4725-9B5D-79988E79FCE9

P478

Q28548038-92E8AC96-9888-4D35-B90D-AAC9169BE189

P577

Q28548038-C34CE7F5-6195-433C-89C4-69BAF8117B39

P5875

Q28548038-B57E2F20-89C6-400A-B707-BF81F91DACCC

P698

Q28548038-DC8C609B-E117-4919-8807-0A0D19112FAF

P921

Q28548038-CD52C27B-90A3-4C67-BFD9-C0F72F0123DB

P932

Q28548038-16E92D99-7A44-4D67-8ADC-62642F995A80

P3181

P356

JOURNAL.PBIO.1002165

P1433

P1476

The Economics of Reproducibility in Preclinical Research

@en

P2093

Iain M Cockburn

http://www.w3.org/2001/XMLSchema#string

Leonard P Freedman

http://www.w3.org/2001/XMLSchema#string

Timothy S Simcoe

http://www.w3.org/2001/XMLSchema#string

P2860

Drug development: Raise standards for preclinical cancer research

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

Tracking replicability as a method of post-publication open evaluation

A call for transparent reporting to optimize the predictive value of preclinical research

Reproducibility of results in preclinical studies: a perspective from the bone field

Biomedical research: increasing value, reducing waste

The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?

Distinguishing between exploratory and confirmatory preclinical research will improve translation

Believe it or not: how much can we rely on published data on potential drug targets?

Policy: NIH plans to enhance reproducibility

P304

e1002165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

540352

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PBIO.1002165

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278046305

http://www.w3.org/2001/XMLSchema#string

P698

26057340

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

P932

4461318

http://www.w3.org/2001/XMLSchema#string